<DOC>
	<DOCNO>NCT02797366</DOCNO>
	<brief_summary>Open label , multi-centre prospective study . Adult patient primary central nervous system tumours fulfil inclusion criterion accord study protocol . The study consist 2 sequential cohort evaluate consecutively feasibility , safety toxicity , well long-term survival data , use spot scan proton beam therapy .</brief_summary>
	<brief_title>Proton Radiotherapy Primary Central Nervous System Tumours Adults</brief_title>
	<detailed_description>Open label , multi-centre prospective phase II study . Adult patient primary central nervous system tumours full-filling inclusion criterion accord study protocol . The study consist 2 sequential cohort evaluate feasibility , safety toxicity , well long-term survival data , use proton beam therapy . - Part I : To assess feasibility use pencil beam scan evaluate treatment safety aspect , assess acute toxicity small cohort CNS patient . All toxicity data , QoL survival data also include part II cohort . - Part II : The second part trial consist CNS patient refer Skandion Clinic safety data first part evaluate study steer committee .</detailed_description>
	<mesh_term>Congenital Abnormalities</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Arteriovenous Malformations</mesh_term>
	<mesh_term>Hemangioma</mesh_term>
	<criteria>Inclusion criterion : The patient must least 18 year old World Health Organization ( WHO ) / Eastern Cooperative OncologyGroup ( ECOG ) performance status 02 , Karnofsky score â‰¥60 . The patient must able understand information treatment give write informed consent participate trial . Adequate followup study must possible ; exclude patient uncooperative . Must life expectancy least 3 year base age comorbidities well diagnosis . For patient consider reirradiation life expectancy must estimate minimum 6 month . Must pathology proven CNS tumour possible , radiology finding must evaluate multidisciplinary conference university hospital . Women reproductive potential must agree use effective method contraception therapy intrauterine device condom . Pregnancy IS ineligibility criterion radiotherapy indicate postponed . Prior CNS radiotherapy ineligibility criterion reirradiated patient include subgroup evaluate separately . Patients discuss multidisciplinary conference one seven university hospital Sweden find candidate radiotherapy one follow diagnosis : Anaplastic glioma grade III Loss Heterozygosity ( LOH ) 1p/19q isocitrate dehydrogenase1 ( IDH1 ) mutation Arteriovenous malformation ( AVMs ) Chordomas chondrosarcoma Craniopharyngiomas Ependymomas Intracranial germ cell tumours Low grade glioma grade III Medulloblastoma , Primitive neuroectodermal tumour ( PNET ) Meningiomas Neurocytoma Other grade III primary CNS tumour accord WHO classification Pituitary adenoma Schwannomas Spinal tumours Whenever craniospinal irradiation ( CSI ) indicate Whenever reirradiation CNS consider Exclusion criterion : Concomitant previous malignancy . Exceptions adequately treat basal cell carcinoma squamous cell carcinoma skin , situ carcinoma cervix uteri followup time least 3 year , previous malignancy diseasefree interval least 5 year . Not able understand information manage test accord study protocol . If necessary , authorized interpreter may use assist translation . Psychiatric addictive disorder medical condition , opinion investigator , would preclude patient meeting study requirement .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>